Table 1 QICH elderly-specific quality indicators
From: The quality of primary care provided to the elderly in Israel
Quality indicator | Denominator | Numerator | Comments |
|---|---|---|---|
Influenza Vaccination | All residents aged 65 years and older during the measurement year | Number of residents (out of the denominator) who received a seasonal influenza vaccination during the measurement year | • “Seasonal” refers to the winter season during the height of the influenza virus, September 1st of the former year to February 28th of current year • Information derived from pharmacy claims and nursing notes |
Pneumococcal Vaccination | All residents aged 65–74 years during the measurement year | Number of residents (out of the denominator) who received the pneumococcal vaccination either once after age 65 or in the last 5 years | • Information derived from pharmacy claims and nursing notes • The 65–74 year age group was selected due to data availability being limited to the past 10 years |
Body Weight and Height Documentation | All residents aged 65–84 years during the measurement year | Number of residents (out of the denominator) with documented body weight during the measurement year and at least one height documentation between 65 and 84 years of age | • Information derived from medical appointment documentation |
Underweight | Number of residents aged 65 or older during the measurement year with body weight and height documentation (see above) | Number of residents (out of the denominator) with most recent documented BMI < 23 kg/m2 | • Information derived from medical appointment documentation |
Weight loss | All residents aged 65 years or older during the measurement year | Number of residents (out of the denominator) experiencing a decline of 10% or more in their body weight within 2 years | • Information derived from medical appointment documentation |
Benzodiazepine Overuse | All residents aged 65 years and older during the measurement year | Number of residents (out of the denominator) with benzodiazepine overuse during the measurement year | • Overused benzodiazepines defined by purchased benzodiazepines or related drugs ≥ 365 DDD/year in the measurement year (DDD = Defined Daily Dose) • Information derived from pharmacy claims |
Benzodiazepine Long-Acting Use | All residents aged 65 years and older during the measurement year | Number of residents (out of the denominator) with at least one purchase of long-acting benzodiazepines during the measurement year | • Long-acting benzodiazepine use defined by the purchase of one or more long-acting benzodiazepines or related drugs • Information derived from pharmacy claims |